Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1660046 · FYE Jun 30 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.10Day +0.00%1Y −34.0%Off 52W high −54.2%Vol (1Y) 88.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,284 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.2d |
| 13F net flow (QoQ)−0.02% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)AUD 7.3M |
| Earnings (TTM)-AUD 5.2M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (AUD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+43.5% |
| 1Y−34.0% |
| 3Y−45.3% |
| 5Y−77.4% |
| Since incept. (ann.)−19.9% |
Total return through 2026-07-29 · series begins 2017-06-09. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)88.8% |
| Ann. volatility (3Y)126.3% |
| Sharpe (1Y)−0.05 |
| Sharpe (3Y)0.26 |
| Max drawdown (1Y)−70.2% |
| Max drawdown (3Y)−84.6% |
| Beta (3Y vs SPY)2.04 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| MORGAN STANLEY | 30,574 | $23,689 | 0.01% | −46.7% |
| XTX Topco Ltd | 17,383 | $13,468 | 0.01% | +23.1% |
| CITADEL ADVISORS LLC | 13,804 | $10,695 | 0.01% | −69.8% |
| TWO SIGMA SECURITIES, LLC | 10,906 | $8,450 | 0.00% | new |
| RHUMBLINE ADVISERS | 7,367 | $5,708 | 0.00% | +63.9% |
| BNP PARIBAS FINANCIAL MARKETS | 4,600 | $3,564 | 0.00% | −2.1% |
| BlackRock, Inc. | 225 | $174 | 0.00% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for IMRN.
